Purpose of Review <p>This review aims to discuss the readiness of ambulatory urodynamics for clinical diagnostic use by the Urologist by examining the accuracy of urodynamic parameter measurements, diagnostic accuracy, ease of use, cost, and to explore its’ limitations.</p> Recent Findings <p>In April 2025 Glean Urodynamics System by BrightUro became the first device with FDA clearance that is clinically available wireless catheter-free ambulatory urodynamics system in the United States that provides accurate continuous pressure sensing.</p> Summary <p>Although not yet adopted as a first line investigation of lower urinary tract function by the International Continence Society, wireless catheter-free ambulatory urodynamics has significant benefits over conventional urodynamics and can be used for clinical diagnosis of lower urinary tract dysfunction in the appropriately selected patient. Limitations are currently being addressed by ongoing clinical trial of a rectally placed abdominal sensor, at-home uroflow devices, and AI (Artifical Intelligence) interpretation tools.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Ambulatory and Wireless Urodynamics: Ready for Clinical Prime Time?

  • Tiffany L. Damm,
  • Jason Kim

摘要

Purpose of Review

This review aims to discuss the readiness of ambulatory urodynamics for clinical diagnostic use by the Urologist by examining the accuracy of urodynamic parameter measurements, diagnostic accuracy, ease of use, cost, and to explore its’ limitations.

Recent Findings

In April 2025 Glean Urodynamics System by BrightUro became the first device with FDA clearance that is clinically available wireless catheter-free ambulatory urodynamics system in the United States that provides accurate continuous pressure sensing.

Summary

Although not yet adopted as a first line investigation of lower urinary tract function by the International Continence Society, wireless catheter-free ambulatory urodynamics has significant benefits over conventional urodynamics and can be used for clinical diagnosis of lower urinary tract dysfunction in the appropriately selected patient. Limitations are currently being addressed by ongoing clinical trial of a rectally placed abdominal sensor, at-home uroflow devices, and AI (Artifical Intelligence) interpretation tools.